OneSource Specialty Pharma consolidated net profit rises 447.95% in the September 2026 quarter

Sales rise 37.39% to Rs 516.24 crore

Net profit of OneSource Specialty Pharma rose 447.95% to Rs 57.48 crore in the quarter ended September 2026 as against Rs 10.49 crore during the previous quarter ended September 2025. Sales rose 37.39% to Rs 516.24 crore in the quarter ended September 2026 as against Rs 375.76 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	516.24	375.76	37
OPM %	31.63	28.34	-
PBDT	129.69	75.57	72
PBT	54.64	5.74	852
NP	57.48	10.49	448

Powered by Capital Market - Live News